InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by LaBrosse Nicole, 首席财务官. Officer active across 1 company, notably Halozyme Therapeutics, INC.. Cumulatively, 17 filings have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €368k. History available since 10 February 2022. The latest transaction was disclosed on 20 February 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to LaBrosse Nicole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
5,332 股0Common StockSEC:0001159036-26-000029:0
5,093 股0Common StockSEC:0001159036-26-000026:0
1,913 股@ US$77.82716.2% 占其流量Common StockSEC:0001910662-25-000003:0
11,271 股@ US$12.0717.8% 占其流量Common StockSEC:0001415889-25-024295:0
6,688 股0Common StockSEC:0001415889-25-005299:0
1,254 股0Common StockSEC:0001415889-25-004507:0
4,008 股@ US$22.5015.5% 占其流量Common StockSEC:0001415889-24-019936:0
10,000 股@ US$22.5039.4% 占其流量Common StockSEC:0001415889-24-018408:0
5,093 股0Common StockSEC:0001415889-24-004475:0
1,254 股0Common StockSEC:0001415889-24-004185:0
2,502 股0Common StockSEC:0001415889-24-003525:0
5,094 股0Common StockSEC:0001415889-23-002954:0
1,254 股0Common StockSEC:0001415889-23-002712:0
2,503 股0Common StockSEC:0001415889-23-002511:0
4,635 股@ US$53.8245.2% 占其流量Common StockSEC:0001415889-22-011459:0
1,255 股0Common StockSEC:0001179110-22-001393:0
2,503 股0Common StockSEC:0001179110-22-001200:0
17 条申报中的 17 条
About LaBrosse Nicole
LaBrosse Nicole is Directeur Financier at Halozyme Therapeutics, INC. She has 17 filings in total, and across the sampled recent filings from 2022-02-14 to 2026-02-24, sales total 367898 EUR and the most frequent transaction nature is Levée d'options.
